Premature Ovarian Insufficiency
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Normally developed women aged 18-40 years; (2) Meet the above-mentioned Western medical diagnostic criteria and the syndrome differentiation criteria of irregular menstruation and kidney deficiency; (3) Did not receive hormone therapy 3 months before enrollment; (4) Those who are willing to participate in this study and sign an informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients who are in the acute inflammatory phase or who use radiotherapy and chemotherapy drugs for tumor diseases; (2) Accompanied by organic diseases such as genital malformations and hypogonadism; (3) Patients with a history of bilateral ovarian resection; (4) People with serious primary diseases such as diabetes, cardiovascular, lung, liver, kidney and hematopoietic system, or other serious diseases that affect fertility; (5) People with mental illnesses such as psychosis, epilepsy and neurosis; (6) Those who are allergic or severely allergic to the test drug; (7) Patients in pregnancy; (8) Those who are participating in other drug clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FSH; | — |
Secondary
| Measure | Time frame |
|---|---|
| LH;E2;AMH;FSHR;INH;ACT;FS;ANA;AOA;ACA;miRNA-23a; | — |
Countries
China
Contacts
Yueyang hospital of Integrated Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine